Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N03 ANTIEPILEPTICS
N03A ANTIEPILEPTICS
N03AX Other antiepileptics
N03AX21 Retigabine
D09569 Ezogabine (USAN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG03199 Antiepileptic agent
DG02037 GABA mimetic antiepileptic
D09569 Ezogabine
Transporter inhibitor
DG01622 ABCB1 inhibitor
D09569 Ezogabine
DG02866 SLC22A8 inhibitor
D09569 Ezogabine
Target-based classification of drugs [BR:br08310]
Ion channels
Voltage-gated ion channels
Potassium channels
KCNQ
D09569 Ezogabine (USAN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D09569
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D09569
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09569
Drug metabolizing enzymes and transporters [br08309.html]
Drug transporters
D09569